IP Library Assignment 037419/0619
Patent Assignment
Reel/Frame 037419/0619

Assignment of Assignor's Interest

Recorded: 2016-01-06 Pages: 3
Assignors
KWOK, DAVID W.K.
Executed: 2003-02-28
STOYNOV, NIKOLAY MINTCHEV
Executed: 2003-02-28
Assignee
PANION & BF BIOTECH INC.
7F NO. 325, SEC. 4, CHUNG HSIAO E. RD., TAIPEI, TAIWAN
Covered Property (1)
Ferric Organic Compounds, Uses Thereof and Methods of Making Same
Patent: 9,328,133 →
Application: 14/502,774 →
Publication: US 2015/0232495
Related Assignments (21)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 6, 2016
From: KWOK, DAVID W.K.; STOYNOV, NIKOLAY MINTCHEV
To: PANION & BF BIOTECH INC.
Reel/Frame 037420/0742 →
Assignment of Assignor's Interest Jan 6, 2016
From: KWOK, DAVID W.K.; STOYNOV, NIKOLAY MINTCHEV
To: PANION & BF BIOTECH INC.
Reel/Frame 037420/0872 →
Assignment of Assignor's Interest Jan 6, 2016
From: PANION & BF BIOTECH INC.
To: GLOBOASIA LLC
Reel/Frame 037421/0023 →
Assignment of Assignor's Interest Jan 6, 2016
From: PANION & BF BIOTECH INC.
To: GLOBOASIA LLC
Reel/Frame 037421/0087 →
Nunc Pro Tunc Assignment Jan 6, 2016
From: GLOBOASIA LLC
To: PANION & BF BIOTECH INC.
Reel/Frame 037421/0234 →
Corrective Assignment to Correct the the Effective Date of the Nunc Pro Tunc Assignment Previously Recorded on Reel 037421 Frame 0234. Assignor(S) Hereby Confirms the Nunc Pro Tunc Assignment with the Effective Date of January 16, 2004 to U.S. Application No. 14502774. Jan 7, 2016
From: GLOBOASIA LLC
To: PANION & BF BIOTECH INC.
Reel/Frame 037459/0787 →
Security Interest Apr 2, 2020
From: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 052295/0662 →
Second Amended and Restated Intellectual Property Security Agreement Sep 2, 2020
From: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 053671/0221 →
Third Amended and Restated Intellectual Property Security Agreement Sep 10, 2020
From: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 054173/0451 →
Fourth Amended and Restated Intellectual Property Security Agreement Dec 17, 2020
From: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 054793/0455 →
Fifth Amended and Restated Intellectual Property Security Agreement Mar 30, 2021
From: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 055776/0491 →
Sixth Amended and Restated Intellectual Property Security Agreement Jun 11, 2021
From: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 056544/0468 →
Seventh Amended and Restated Intellectual Property Security Agreement Sep 12, 2021
From: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 057474/0770 →
Security Interest Dec 15, 2021
From: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 058399/0055 →
Tenth Amended and Restated Intellectual Property Security Agreement Jun 16, 2022
From: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 060529/0168 →
Eleventh Amended and Restated Intellectual Property Security Agreement Aug 22, 2022
From: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 061297/0238 →
Twelfth Amended and Restated Intellectual Property Security Agreement Nov 29, 2022
From: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 062012/0561 →
Thirteenth Amended and Restated Intellectual Property Security Agreement Mar 29, 2023
From: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 063189/0065 →
Fifteenth Amended and Restated Intellectual Property Security Agreement Jan 4, 2024
From: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 066205/0143 →
Termination and Release of Security Interest in Patents Jan 29, 2024
From: BIOPHARMA CREDIT PLC
To: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
Reel/Frame 066377/0741 →
Termination and Release of Security Interest in Patents Jun 25, 2024
From: BIOPHARMA CREDIT PLC
To: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
Reel/Frame 067839/0134 →